{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:57:57Z","timestamp":1791349077173,"version":"4.3.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.nucmedbio.2011.09.008","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T22:14:53Z","timestamp":1323123293000},"page":"315-323","source":"Crossref","is-referenced-by-count":14,"title":["Fluorine-18 labeling of three novel d-peptides by conjugation with N-succinimidyl-4-[18F]fluorobenzoate and preliminary examination by postmortem whole-hemisphere human brain autoradiography"],"prefix":"10.1016","volume":"39","author":[{"given":"Mahabuba","family":"Jahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangram","family":"Nag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raisa","family":"Krasikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Muhs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Spenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Willbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Guly\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Halldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0005","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","article-title":"Alzheimer disease in the US population \u2014 prevalence estimates using the 2000 census","volume":"60","author":"Hebert","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0010","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0025","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0030","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2174\/1381612013396871","article-title":"PET studies with carbon-11 radioligands in neuropsychopharmacological drug development","volume":"7","author":"Halldin","year":"2001","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0035","first-page":"594","article-title":"Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging","volume":"45","author":"Silverman","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0040","first-page":"139","article-title":"Brain radioligands \u2014 state of the art and new trends","volume":"45","author":"Halldin","year":"2001","journal-title":"Q J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0045","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0050","first-page":"584","article-title":"In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET","volume":"12","author":"Verhoeff","year":"2004","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00019442-200201000-00004","article-title":"Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease","volume":"10","author":"Shoghi-Jadid","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0060","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2967\/jnumed.109.069088","article-title":"In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (Florbetapir F 18)","volume":"51","author":"Wong","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","article-title":"Imaging of amyloid \u03b2 in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism","volume":"7","author":"Rowe","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0070","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00259-009-1182-1","article-title":"Detection of amyloid in Alzheimer's disease with positron emission tomography using [11C]AZD2184","volume":"36","author":"Nyberg","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0075","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00259-009-1301-z","article-title":"Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease","volume":"37","author":"N\u00e5gren","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0022-2836(91)90881-6","article-title":"Aggregation and secondary structure of synthetic amyloid \u03b2A4 peptides of Alzheimer's disease","volume":"218","author":"Hilbich","year":"1991","journal-title":"J Mol Biol"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0085","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/44973","article-title":"Alzheimer's disease \u2014 a firm base for drug development","volume":"402","author":"De Strooper","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0090","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1021\/ja00036a073","article-title":"A racemic protein","volume":"114","author":"Zawadzke","year":"1992","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/(SICI)1097-4695(19990605)39:3<371::AID-NEU4>3.0.CO;2-E","article-title":"\u03b2-Sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood\u2013brain barrier permeability and resistance to proteolytic degradation in plasma","volume":"39","author":"Poduslo","year":"1999","journal-title":"J Neurobiol"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0100","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1021\/bi982824n","article-title":"Modified-peptide inhibitors of amyloid \u03b2-peptide polymerization","volume":"38","author":"Findeis","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0105","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/prot.340160309","article-title":"A comparison of the immunogenicity of a pair of enantiomeric proteins","volume":"16","author":"Dintzis","year":"1993","journal-title":"Proteins"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0110","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1126\/science.271.5257.1854","article-title":"Identification of d-peptide ligands through mirror-image phage display","volume":"271","author":"Schumacher","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0161-5890(97)00004-7","article-title":"On the immunogenic properties of retro-inverso peptides. Total retro-inversion of T-cell epitopes causes a loss of binding to MHC II molecules","volume":"34","author":"Herv\u00e9","year":"1997","journal-title":"Mol Immunol"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0092-8674(00)80066-5","article-title":"Inhibiting HIV-1 entry: discovery of d-peptide inhibitors that target the gp41 coiled-coil pocket","volume":"99","author":"Eckert","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0125","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1039\/b904138a","article-title":"Mirror image phage display-a method to generate d-peptide ligands for use in diagnostic or therapeutical applications","volume":"5","author":"Funke","year":"2009","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0130","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/cbic.200300631","article-title":"Selection of d-amino-acid peptides that bind to Alzheimer's disease amyloid peptide A\u03b21-42 by mirror image phage display","volume":"4","author":"Wiesehan","year":"2003","journal-title":"ChemBioChem"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0135","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/13.8.693","article-title":"Congo red as a stain for fluorescence microscopy of amyloid","volume":"13","author":"Puchtler","year":"1965","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/abio.1998.2933","article-title":"Quantifying amyloid \u03b2-peptide (A\u03b2) aggregation using the Congo red A\u03b2 (CR-A\u03b2) spectrophotometric assay","volume":"266","author":"Klunk","year":"1999","journal-title":"Anal Biochem"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0145","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/cmdc.200800289","article-title":"In vitro and in vivo staining characteristics of small, fluorescent, A\u03b242-binding d-enantiomeric peptides in transgenic AD mouse models","volume":"4","author":"Van Groen","year":"2009","journal-title":"ChemMed-Chem"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0150","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/rej.2009.0924","article-title":"Differently selected d-enantiomeric peptides act on different A\u03b2 species","volume":"13","author":"Bartnik","year":"2010","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0155","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1042\/CS103S004S","article-title":"18F-endothelin-1, a positron emission tomography (PET) radioligand for the endothelin receptor system: radiosynthesis and in vivo imaging using microPET","volume":"103","author":"Johnstr\u00f6m","year":"2002","journal-title":"Clin Sci"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0160","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/jlcr.2580270711","article-title":"Aryltrimethylammonium trifluoromethanesulfonates as precursors to aryl [18F]fluorides-improved synthesis of [18F]GBR-13119","volume":"27","author":"Haka","year":"1989","journal-title":"J Labelled Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jlcr.1481","article-title":"Facile synthesis of N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB) for protein labeling","volume":"51","author":"Tang","year":"2008","journal-title":"J Labelled Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0170","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.nucmedbio.2008.04.005","article-title":"Automated synthesis of the generic peptide labelling agent N-succinimidyl 4-[18F]fluorobenzoate and application to 18F-label the vasoactive transmitter urotensin-II as a ligand for positron emission tomography","volume":"35","author":"Johnstr\u00f6m","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0175","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0969-8051(98)00053-5","article-title":"Whole hemisphere autoradiography of the postmortem human brain","volume":"25","author":"Hall","year":"1998","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/09540260020024141","article-title":"Human brain imaging post-mortem - whole hemisphere technologies","volume":"13","author":"Hall","year":"2001","journal-title":"Int Rev Psychiatry"},{"issue":"Pt 3","key":"10.1016\/j.nucmedbio.2011.09.008_bb0185","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/brain\/awq383","article-title":"Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease","volume":"134","author":"Ch\u00e9telat","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nucmedbio.2011.09.008_bb0190","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1471-4159.2008.05861.x","article-title":"AZD2184: a radioligand for sensitive detection of beta-amyloid deposits","volume":"108","author":"Johnson","year":"2009","journal-title":"J Neurochem"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805111002290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805111002290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T10:06:15Z","timestamp":1561025175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805111002290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0969805111002290"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2011.09.008","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}